hNIS-based imaging to monitor treatment with the novel oncolytic virus CF33-hNIS-antiPDL1 in humans with advanced triple negative breast cancer

20250 citationsJournal Articlegold Open Access

Authors

https://www.clinicaltrials.gov/study/NCT05081492, identifier NCT05081492.

Published in: Frontiers in Oncology

Volume 15, pp. 1565244-1565244

Field-Weighted Citation Impact: 0.00